The DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation
Open accessAbstract
The Ras-extracellular signal-regulated kinase (Ras-ERK) and phosphatidylinositol 3-kinase-mammalian target of rapamycin (PI3K-mTOR) signaling pathways are the chief mechanisms for controlling cell survival, differentiation, proliferation, metabolism, and motility in response to extracellular cues. Components of these pathways were among the first to be discovered when scientists began cloning proto-oncogenes and purifying cellular kinase activities in the 1980s. Ras-ERK and PI3K-mTOR were originally modeled as linear signaling conduits activated by different stimuli, yet even early experiments hinted that they might intersect to regulate each other and co-regulate downstream functions. The extent of this cross-talk and its significance in cancer therapeutics are now becoming clear.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“An additional layer of complexity is the cross-regulation between the two pathways with ERK signaling feeding into several nodes of PI3K/mTOR such as its phosphorylation of TSC236–38.”
From Combined inhibition of KRASG12C and mTORC1 kinase is synergistic in non-small cell lung cancer (2024) · cites this paper as [36]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cell Signaling by Receptor Tyrosine Kinases
Lemmon, M. A., & Schlessinger, J. (2010) · Cell · doi:10.1016/j.cell.2010.06.011 · Cited by 7,929
AKT/PKB signaling: navigating downstream
Manning, B. D., & Cantley, L. C. (2007) · Cell · doi:10.1016/j.cell.2007.06.009 · Cited by 6,115
mTOR: from growth signal integration to cancer, diabetes and ageing
Zoncu, R., Efeyan, A., & Sabatini, D. M. (2011) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3025 · Cited by 3,941
Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
Flaherty, K. T., Puzanov, I., Kim, K. B., Ribas, A., McArthur, G. A., Sosman, J. A., O'Dwyer, P. J., Lee, R. J., Grippo, J. F., Nolop, K., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1002011 · Cited by 3,103
MAP kinase signalling pathways in cancer
Dhillon, A. S., Hagan, S., Rath, O., & Kolch, W. (2007) · Oncogene · doi:10.1038/sj.onc.1210421 · Cited by 2,995
Zha, J., Harada, H., Yang, E., Jockel, J., & Korsmeyer, S. J. (1996) · Cell · doi:10.1016/s0092-8674(00)81382-3 · Cited by 2,578
Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulation
Nazarian, R., Shi, H., Wang, Q., Kong, X., Koya, R. C., Lee, H., Chen, Z., Lee, M., Attar, N., Sazegar, H., et al. (2010) · Nature · doi:10.1038/nature09626 · Cited by 2,244
Phosphatidylinositol-3-OH kinase direct target of Ras
Rodriguez-Viciana, P., Warne, P. H., Dhand, R., Vanhaesebroeck, B., Gout, I., Fry, M. J., Waterfield, M. D., & Downward, J. (1994) · Nature · doi:10.1038/370527a0 · Cited by 1,954
Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., & Greenberg, M. E. (1999) · Science · doi:10.1126/science.286.5443.1358 · Cited by 1,908
COT drives resistance to RAF inhibition through MAP kinase pathway reactivation
Johannessen, C. M., Boehm, J. S., Kim, S. Y., Thomas, S. R., Wardwell, L., Johnson, L. A., Emery, C. M., Stransky, N., Cogdill, A. P., Barretina, J., et al. (2010) · Nature · doi:10.1038/nature09627 · Cited by 1,460
Flagged first, then by citations
2 of the 103 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 801–900 of 1,004
Fabi, F., Adam, P., Parent, S., Tardif, L., Cadrin, M., & Asselin, É. (2020) · Molecular Oncology · doi:10.1002/1878-0261.12888 · Cited by 23
Blondy, S., Hugo Talbot, A., Saada, S., Christou, N., Battu, S., Pannequin, J., Jauberteau, M., Lalloué, F., Verdier, M., Mathonnet, M., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15752 · Cited by 22
The pleiotropic roles of circular and long noncoding RNAs in cutaneous melanoma
Montico, B., Giurato, G., Pecoraro, G., Salvati, A., Covre, A., Colizzi, F., Steffan, A., Weisz, A., Maio, M., Sigalotti, L., et al. (2021) · Molecular Oncology · doi:10.1002/1878-0261.13034 · Cited by 22
Lin, F., de Gooijer, M. C., Hanekamp, D., Brandsma, D., Beijnen, J. H., & van Tellingen, O. (2013) · CNS Oncology · doi:10.2217/cns.13.15 · Cited by 24
MT-125 inhibits non-muscle myosin IIA and IIB and prolongs survival in glioblastoma
Kenchappa, R. S., Radnai, L., Young, E. J., Zarco, N., Lin, L., Dovas, A., Meyer, C. T., Haddock, A., Hall, A., Toth, K., et al. (2025) · Cell · doi:10.1016/j.cell.2025.05.019 · Cited by 21
Ren, H. J., Guo, H., Thakur, A., Zhang, S., Wang, T., Liang, Y., Shi, P., Gao, L., Liu, F., Feng, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11645 · Cited by 21
Dexmedetomidine protects against sepsis‑associated encephalopathy through Hsp90/AKT signaling
Yin, L., Chen, X., Ji, H., & Gao, S. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10718 · Cited by 20
Sato, A., & Ikeda, K. (2021) · Biological Psychiatry Global Open Science · doi:10.1016/j.bpsgos.2021.08.005 · Cited by 22
Ruminant Placental Adaptation in Early Maternal Undernutrition: An Overview
Toschi, P., & Baratta, M. (2021) · Frontiers in Veterinary Science · doi:10.3389/fvets.2021.755034 · Cited by 21
Multidisciplinary Management of Costello Syndrome: Current Perspectives
Leoni, C., Viscogliosi, G., Tartaglia, M., Aoki, Y., & Zampino, G. (2022) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s291757 · Cited by 21
Molecular Mechanism of Tanshinone against Prostate Cancer
Li, W., Huang, T., Xu, S., Che, B., Yu, Y., Zhang, W., & Tang, K. (2022) · Molecules · doi:10.3390/molecules27175594 · Cited by 21
Cannabidiol Modulates Alterations in PFC microRNAs in a Rat Model of Depression
Bright, U., & Akirav, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032052 · Cited by 21
Arekatla, G., Trenzinger, C., Reimann, A., Loeffler, D., Kull, T., & Schroeder, T. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.04.013 · Cited by 19
Geiselmann, A., Micouin, A., Vandormael‐Pournin, S., Laville, V., Chervova, A. A., Mella, S., Navarro, P., & Cohen‐Tannoudji, M. (2024) · Developmental Cell · doi:10.1016/j.devcel.2024.10.001 · Cited by 18
Locatelli, S. L., Careddu, G., Stirparo, G. G., Castagna, L., Santoro, A., & Carlo‐Stella, C. (2016) · Scientific Reports · doi:10.1038/srep35745 · Cited by 21
Bashash, D., Safaroghli‐Azar, A., Dadashi, M., Safa, M., Momeny, M., & Ghaffari, S. H. (2017) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2017.02.007 · Cited by 21
Heterogeneous Reciprocal Graphical Models
Ni, Y., Müller, P., Zhu, Y., & Ji, Y. (2017) · Biometrics · doi:10.1111/biom.12791 · Cited by 23
Overexpression of Na+/Mg2+ exchanger SLC41A1 attenuates pro-survival signaling
Sponder, G., Abdulhanan, N., Fröhlich, N., Mastrototaro, L., Aschenbach, J. R., Röntgen, M., Pilchová, I., Cibulka, M., Račay, P., & Kolísek, M. (2017) · Oncotarget · doi:10.18632/oncotarget.23598 · Cited by 21
Chang, H., Wei, J.-W., Tao, Y., Ding, P., Xia, Y., Gao, Y., & Xiao, W. (2017) · Cancer Research and Treatment · doi:10.4143/crt.2017.538 · Cited by 21
Vauzour, D., Corsini, S., Müller, M. M., & Spencer, J. P. E. (2018) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2018.04.020 · Cited by 21
Li, T., Deng, Y., Shi, Y., Tian, R., Chen, Y., Zou, L., Kazi, J. U., Rönnstrand, L., Feng, B., Chan, S. O., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0397-7 · Cited by 21
Arosh, J. A., & Banu, S. K. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.12.011 · Cited by 20
Hou, B., Wang, G., Gao, Q., Wei, Y., Zhang, C., Wang, Y., Huo, Y., Yang, H., Jiang, X., & Xi, Z. (2019) · Scientific Reports · doi:10.1038/s41598-019-47597-4 · Cited by 21
Peng, M., Deng, J., Zhou, S., Xiao, D., Long, J., Zhang, N., He, C., Mo, M., & Yang, X. (2019) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01159 · Cited by 21
Cabrera‐Andrade, A., López‐Cortés, A., Jaramillo-Koupermann, G., Paz‐y‐Miño, C., Pérez‐Castillo, Y., Munteanu, C. R., González‐Díaz, H., Pazos, A., & Tejera, E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21031053 · Cited by 21
Carboxypeptidase A4 promotes cardiomyocyte hypertrophy through activating PI3K-AKT-mTOR signaling
Gao, W., Guo, N., Zhao, S., Chen, Z., Zhang, W., Yan, F., Liao, H., & Chi, K. (2020) · Bioscience Reports · doi:10.1042/bsr20200669 · Cited by 21
Abbruzzese, G., Morón-Oset, J., Díaz-Castroverde, S., García-Font, N., Roncero, C., Lopez-Munoz, F. J., Marco, J. L., & Oset‐Gasque, M. J. (2020) · Antioxidants · doi:10.3390/antiox9060545 · Cited by 22
Ye, D., Hao, Z., Tang, S., Velkov, T., & Dai, C. (2024) · Biomolecules · doi:10.3390/biom14111460 · Cited by 20
Sk, M. A., Hemalatha, K., Matada, G. S. P., Pal, R., Manjushree, B. V., Mounika, S., Haripriya, E., Viji, M. P., & Anjan, D. (2024) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2024.108011 · Cited by 22
Wang, Y., Xie, L., Liu, F.-Y., Ding, D., Wei, W., & Han, F. (2023) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2023.117299 · Cited by 21
Zhang, Y., Li, H., Chen, Y., Fang, H., Yu, Y., Liu, J. H., Jing, Z., Wang, Z., & Wang, Y. (2013) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12205 · Cited by 20
Zhang, C., Yang, L., Geng, Y., An, F., Xia, Y., Guo, C., Luo, J., Zhang, L., Guo, Q., & Kong, L. (2016) · Oncotarget · doi:10.18632/oncotarget.8538 · Cited by 20
Inaba, K., Oda, K., Aoki, K., Sone, K., Ikeda, Y., Miyasaka, A., Kashiyama, T., Fukuda, T., Makii, C., Arimoto, T., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.8807 · Cited by 20
Breast Cancer: A Molecular and Redox Snapshot
Raman, D., Foo, C. H. J., Clement, M., & Pervaiz, S. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6546 · Cited by 20
Bradley, R. M., Mardian, E. B., Bloemberg, D., Henao, J. J. A., Mitchell, A. S., Marvyn, P. M., Moes, K. A., Stark, K. D., Quadrilatero, J., & Duncan, R. E. (2017) · Molecular and Cellular Biology · doi:10.1128/mcb.00245-17 · Cited by 20
Dolgikh, N., Hugle, M., Vogler, M., & Fulda, S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-1737 · Cited by 19
Diethylnitrosamine induces lung adenocarcinoma in FVB/N mouse
Mervai, Z., Egedi, K., Kovalszky, I., & Baghy, K. (2018) · BMC Cancer · doi:10.1186/s12885-018-4068-4 · Cited by 20
A New Linkage between the Tumor Suppressor RKIP and Autophagy: Targeted Therapeutics
Wang, Y., & Bonavida, B. (2018) · Critical Reviews™ in Oncogenesis · doi:10.1615/critrevoncog.2018027211 · Cited by 19
The Secret Life of Translation Initiation in Prostate Cancer
Hernández, G., Ramírez, J. L., Pedroza‐Torres, A., Herrera, L. A., & Jiménez-Ríos, M. Á. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00014 · Cited by 22
Moeller, T., Wolfheimer, S., Goretzki, A., Scheurer, S., & Schülke, S. (2019) · Cells · doi:10.3390/cells8040355 · Cited by 21
Rabhi, C., Arcile, G., Goff, G. L., Noble, C. D. C., & Ouazzani, J. (2019) · Molecules · doi:10.3390/molecules24244599 · Cited by 20
Anti‐angiogenic effects of the blue‐green alga Arthrospira platensis on pancreatic cancer
Markova, I., Koníčková, R., Vaňková, K., Leníček, M., Kolář, M., Strnad, H., Hradilová, M., Šáchová, J., Rasl, J., Klímová, Z., et al. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.14922 · Cited by 19
Shafei, M. A., Forshaw, T. E., Davis, J., Flemban, A. F., Qualtrough, D., Dean, S., Perks, C. M., Dong, M., Newman, R. H., & Conway, M. E. (2020) · Oncotarget · doi:10.18632/oncotarget.27607 · Cited by 20
The two sides of HER2/neu: immune escape versus surveillance
Seliger, B., & Kiessling, R. W. (2013) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2013.08.003 · Cited by 20
A Systems-Level Interrogation Identifies Regulators of Drosophila Blood Cell Number and Survival
Sopko, R., Lin, Y. B., Makhijani, K., Alexander, B., Perrimon, N., & Brückner, K. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005056 · Cited by 19
Decoding the crosstalk between mevalonate metabolism and T cell function
Kennewick, K. T., & Bensinger, S. J. (2023) · Immunological Reviews · doi:10.1111/imr.13200 · Cited by 20
Haprolid Inhibits Tumor Growth of Hepatocellular Carcinoma through Rb/E2F and Akt/mTOR Inhibition
Xing, J., Bhuria, V., Bùi, K. C., Nguyen, M. L. T., Hu, Z., Hsieh, C., Wittstein, K., Stadler, M., Wilkens, L., Li, J., et al. (2020) · Cancers · doi:10.3390/cancers12030615 · Cited by 19
Hernández-Padilla, L., de la Cruz, H. R., & Campos‐García, J. (2020) · APOPTOSIS · doi:10.1007/s10495-020-01619-z · Cited by 19
Zhu, Z., Ma, G., Yang, M., Tan, C., Yang, G., Wang, S., Li, N., Ge, F., & Wang, S. (2021) · Environmental Microbiology · doi:10.1111/1462-2920.15626 · Cited by 19
Wei, S., Yao, X., Wang, C.-T., Dong, A.-Q., Li, D., Zhang, Y., Ren, C., Zhang, J., Mao, C., Wang, F., et al. (2021) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2021.10.015 · Cited by 19
Rabionet, M., Polonio‐Alcalá, E., Relat, J., Yeste, M., Sims‐Mourtada, J., Kloxin, A. M., Planas, M., Feliu, L., Ciurana, J., & Puig, T. (2021) · Materials Today Bio · doi:10.1016/j.mtbio.2021.100155 · Cited by 19
Estévez-Silva, H. M., Cuesto, G., Romero, N., Armas, J. M. B., Acevedo‐Arozena, A., Acebes, Á., & Marcellino, D. J. (2022) · Neurotherapeutics · doi:10.1007/s13311-022-01280-1 · Cited by 19
VEGFR-3 signaling restrains the neuron-macrophage crosstalk during neurotropic viral infection
Qi, L., Li, X., Zhang, F., Zhu, X., Zhao, Q., Yang, D., Hao, S., Li, T., Li, X., Tian, T., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112489 · Cited by 18
Wang, N., Gao, E., Cui, C., Wang, F., Ren, H., Xu, C., Cancan, N. I. N. G., Zheng, Y., Liu, Q., Yu, Q., et al. (2023) · Food Science & Nutrition · doi:10.1002/fsn3.3590 · Cited by 18
Pomerleau, V., Landry, M., Bernier, J., Vachon, P. H., & Saucier, C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-240 · Cited by 19
Wang, Q., Feng, W., Li, C., Lv, G., Wang, G., Liu, T., Bellail, A. C., & Hao, C. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073175 · Cited by 19
RetractedDabbah, M., Attar‐Schneider, O., Zismanov, V., Matalon, S. T., Lishner, M., & Drucker, L. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.3a1115-510rr · Cited by 19
Song, Q., Sun, X., Guo, H., & Yu, Q. (2016) · Oncotarget · doi:10.18632/oncotarget.14009 · Cited by 19
Fluoxetine Modulates the Activity of Hypothalamic POMC Neurons via mTOR Signaling
Barone, I., Melani, R., Mainardi, M., Scabia, G., Scali, M., Dattilo, A., Ceccarini, G., Vitti, P., Santini, F., Maffei, L., et al. (2018) · Molecular Neurobiology · doi:10.1007/s12035-018-1052-6 · Cited by 20
Yu, V. Z., Ko, J. M. Y., Ning, L., Dai, W., Law, S. Y.-K., & Lung, M. L. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.07.005 · Cited by 19
Kim, S., Baik, J. S., Lee, J.-H., Mun, S.-W., Yi, J. M., & Park, M.-T. (2020) · Journal of Radiation Research · doi:10.1093/jrr/rraa002 · Cited by 19
Khoury, J. D., Tashakori, M., Yang, H. Y., Loghavi, S., Wang, Y., Wang, J., Piya, S., & Borthakur, G. M. (2020) · Cancers · doi:10.3390/cancers12123511 · Cited by 19
Arcucci, S., Ramos-Delgado, F., Cayron, C., Therville, N., Gratacap, M., Basset, C., Thibault, B., & Guillermet-Guibert, J. (2021) · Biochemical Journal · doi:10.1042/bcj20210004 · Cited by 15
Jandhyala, D. M., Ahluwalia, A., Schimmel, J. J., Rogers, A. B., Leong, J. M., & Thorpe, C. M. (2015) · Infection and Immunity · doi:10.1128/iai.00977-15 · Cited by 19
mTOR inhibitor efficacy is determined by the eIF4E/4E-BP ratio
Alain, T., Sonenberg, N., & Topisirović, I. (2012) · Oncotarget · doi:10.18632/oncotarget.799 · Cited by 19
Integrin β1 regulates marginal zone B cell differentiation and PI3K signaling
Andreani, V., Ramamoorthy, S., Fässler, R., & Grosschedl, R. (2023) · Journal of Experimental Medicine · doi:10.1084/jem.20220342 · Cited by 18
Stepanenko, A. A., Andreieva, S. V., Korets, K. V., Mykytenko, D. O., Baklaushev, V. P., Chekhonin, V. P., & Dmitrenko, V. V. (2015) · Gene · doi:10.1016/j.gene.2015.12.064 · Cited by 19
Sun, Y.-H., Bu, R., Wang, Y., Hu, Y., Wang, X., Dong, X., Zu, W., Niu, Y., Zhao, P., Sun, P. G., et al. (2021) · Scientific Reports · doi:10.1038/s41598-020-80861-6 · Cited by 18
Kaiserman, J., O’Hara, B. A., Haley, S. A., & Atwood, W. J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24108580 · Cited by 18
Brown, W., Wesalo, J. S., Samanta, S., Luo, J., Caldwell, S. E., Tsang, M., & Deiters, A. (2023) · ACS Chemical Biology · doi:10.1021/acschembio.3c00028 · Cited by 18
MEK inhibitors: a promising targeted therapy for cardiovascular disease
Mohammed, K. A. K., Madeddu, P. R., & Avolio, E. (2024) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2024.1404253 · Cited by 18
S6 Kinase is essential for MYC-dependent rDNA transcription in Drosophila
Mitchell, N. C., Tchoubrieva, E. B., Chahal, A., Woods, S. J., Lee, A., Lin, J. I., Parsons, L. M., Jastrzebski, K., Poortinga, G., Hannan, K. M., et al. (2015) · Cellular Signalling · doi:10.1016/j.cellsig.2015.07.018 · Cited by 18
Caravagna, C., & Soliz, J. (2014) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2014.11.012 · Cited by 18
Yang, W., Wang, Y., Wang, Y., Zhang, J., Zhang, J., Lu, C., & Wang, X. (2015) · Molecular Reproduction and Development · doi:10.1002/mrd.22473 · Cited by 18
Regulation of therapeutic resistance in cancers by receptor tyrosine kinases.
Chen, M., & Hung, M. (2016) · PubMed · Cited by 18
Ma, L., Li, K., Guo, Y., Sun, X., Deng, H., Li, K., Feng, Q., & Li, S. (2018) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2018.01.007 · Cited by 18
Adult Neural Stem Cells: Basic Research and Production Strategies for Neurorestorative Therapy
Samoilova, E. M., Анатольевич, К. В., Kushnir, N. M., Chistyakov, D. A., Troitskiy, A. V., & Baklaushev, V. P. (2018) · Stem Cells International · doi:10.1155/2018/4835491 · Cited by 18
A Polyphenol-Rich Extract From Muscadine Grapes Inhibits Triple-Negative Breast Tumor Growth
Collard, M., Gallagher, P. E., & Tallant, E. A. (2020) · Integrative Cancer Therapies · doi:10.1177/1534735420917444 · Cited by 18
Zoledronate Extends Health Span and Survival via the Mevalonate Pathway in a FOXO-dependent Manner
Chen, Z., Cordero, J. B., Alqarni, A. M., Slack, C., Zeidler, M. P., & Bellantuono, I. (2021) · The Journals of Gerontology Series A · doi:10.1093/gerona/glab172 · Cited by 17
Qu, G., Shi, M., Wang, D., Wu, J., Wang, P., Gong, M., & Zhang, Z. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01571-x · Cited by 18
Eaton-Fitch, N., Cabanas, H., Preez, S. D., Staines, D., & Marshall‐Gradisnik, S. (2021) · Journal of Translational Medicine · doi:10.1186/s12967-021-02974-4 · Cited by 18
Lin, Y., Papp, G., Miskey, C., Fiedler, A. H., Goretzki, A., Wolfheimer, S., Zimmermann, J., Crauwels, P., Ivics, Z., van Zandbergen, G., et al. (2021) · Cells · doi:10.3390/cells10102614 · Cited by 18
Effects of mTOR Inhibitors on Components of the Salvador-Warts-Hippo Pathway
Chiang, J., & Martínez-Agosto, J. A. (2012) · Cells · doi:10.3390/cells1040886 · Cited by 19
Effects of BP-14, a novel cyclin-dependent kinase inhibitor, on anaplastic thyroid cancer cells
Allegri, L., Baldan, F., Mio, C., Puppin, C., Russo, D., Kryštof, V., & Damante, G. (2016) · Oncology Reports · doi:10.3892/or.2016.4614 · Cited by 18
Liu, C., Zhang, W., Peradze, N., Láng, L., Straetener, J., Feilen, P. J., Alt, M., Jäger, C., Laubner, K., Perakakis, N., et al. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2018.01.024 · Cited by 18
Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy
Gitareja, K., Chelliah, S. S., Sanij, E., Sandhu, S. K., Kang, J., & Khot, A. S. (2025) · Cancers · doi:10.3390/cancers17152534 · Cited by 20
Fritsche‐Guenther, R., Witzel, F., Kempa, S., Brummer, T., Sers, C., & Blüthgen, N. (2016) · Oncotarget · doi:10.18632/oncotarget.6959 · Cited by 18
Chiang, C.-K., Tworak, A., Kevany, B. M., Xu, B., Mayne, J., Ning, Z., Figeys, D., & Palczewski, K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.812677 · Cited by 17
DEPTOR inhibits lung tumorigenesis by inactivating the EGFR-mTOR signals
Gong, L., Shu, J., Chen, X., Pan, H., Chen, G., Bi, Y., Cui, D., Li, X., Liu, D., Wang, L., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.07.031 · Cited by 18
Relating individual cell division events to single-cell ERK and Akt activity time courses
Stern, A. D., Smith, G. R., SANTOS, L. V. D. S., Sarmah, D., Zhang, X., Lu, X., Iuricich, F., Pandey, G. S., Iyengar, R., & Birtwistle, M. R. (2022) · Scientific Reports · doi:10.1038/s41598-022-23071-6 · Cited by 19
Smolen, K. A., Papke, C. M., Swingle, M. R., Musiyenko, A., Li, C., Salter, E. A., Camp, A. D., Honkanen, R. E., & Kettenbach, A. N. (2023) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105154 · Cited by 17
Meng, L., Yang, J., Gao, Y., Cao, Q., Jiang, S.-J., Xiao, Y., Wang, H., Liu, W., Yuan, A., Li, Y., et al. (2024) · ACS Nano · doi:10.1021/acsnano.3c10129 · Cited by 18
Fatal attractions that trigger inflammation and drive atherosclerotic disease
Sharma, H., Mossman, K. L., & Austin, R. C. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14169 · Cited by 17
You, Q., Li, R., Yao, J., Zhang, Y., Sui, X. Y., Xiao, C., Zhang, J.-B., Xiao, J., Chen, H., Li, H., et al. (2024) · Medical Oncology · doi:10.1007/s12032-023-02295-0 · Cited by 18
Bullock, K. K., & Richmond, A. J. (2024) · Cancers · doi:10.3390/cancers16122189 · Cited by 18
Cutshaw, G., Joshi, N., Wen, X., Quam, E., Bogatcheva, G., Hassan, N. A., Uthaman, S., Waite, J. R., Sarkar, S., Singh, B., et al. (2024) · Angewandte Chemie International Edition · doi:10.1002/anie.202410919 · Cited by 19
Wu, K., Zhao, Y., He, Y. Z., Wang, B., Du, K., Fu, S., Hu, K., Zhang, L., Liu, L., Hu, Y., et al. (2013) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428194.2013.811579 · Cited by 17
Li, S., Liu, J., Tan, J., Li, L., Kaltreider, M. J., Zhao, J., Kass, D. J., Shang, D., & Zhao, Y. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00093.2018 · Cited by 18
Saraf, R., Datta, A. A., Sima, C., Hua, J., Lopes, R., & Bittner, M. L. (2018) · BMC Cancer · doi:10.1186/s12885-018-4756-0 · Cited by 17
An Optogenetic Method to Study Signal Transduction in Intestinal StemCell Homeostasis.
Bunnag, N., Tan, Q.-H., Kaur, P., Ramamoorthy, A., Sung, I. C. H., Lusk, J. B., & Tolwinski, N. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.03.019 · Cited by 14
Metadata
- Authors
- Mendoza, M. C., Er, E. E., & Blenis, J.
- Affiliations
- Harvard University (US)
- Corresponding author
- Blenis, John
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 2011-06
- Volume
- 36
- Issue
- 6
- Pages
- 320-328
- ISSN
- 0968-0004 (ISSN-L)
- PMC
- PMC3112285
- OpenAlex
- W1998203489
- Cited by
- 1,817
- References
- 103
- Citations by year
- 2026: 112 · 2025: 96 · 2024: 122 · 2023: 133 · 2022: 127 · 2021: 163 · 2020: 166 · 2019: 164 · 2018: 144 · 2017: 158 · 2016: 123 · 2015: 100 · 2014: 92 · 2013: 55 · 2012: 49
- FWCI
- 5.82
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Trends in Biochemical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- LAM Foundation
- Susan G. Komen
- National Cancer Institute (R37CA046595)
- National Institute of General Medical Sciences (R01GM051405)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- Ras/ERK signaling pathway, signaling crosstalk, cell survival, cell proliferation, cell differentiation, cellular metabolism, cell motility, proto-oncogenes, cancer therapeutics
- MeSH terms
- Humans, Signal Transduction, ras Proteins, Extracellular Signal-Regulated MAP Kinases, Phosphatidylinositol 3-Kinase, TOR Serine-Threonine Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review